FUJIFILM Corporation today announced the completion of one of Japan’s largest bio CDMO*1 facilities (the new plant) at the ...
Global 3D Bioprinting Market OverviewThe global 3D bioprinting market is poised for strong growth, with projections indicating a compound annual growth rate of 12–15% over the next five years. This ...
The latest announcement is out from BullFrog AI Holdings, Inc. ( ($BFRG) ). In a December 30, 2025 letter to shareholders, BullFrog AI detailed a ...
A Comprehensive OverviewThe global Peptide Cancer Vaccine Market is valued at USD 1.2 Billion in 2025 and is projected to reach a value of USD 15.72 Billion by 2035 at a CAGR (Compound Annual Growth ...
The global market for contract manufacturing of medical devices is estimated to grow from $96.4 billion in 2025 to reach $155.2 billion by 2030, at a compound annual growth rate (CAGR) of 10% from ...
Morning Overview on MSN
A new drug may stop Alzheimer’s before memory loss starts
Alzheimer’s disease has long been a diagnosis that arrives only after memory begins to fray, by which time brain damage is ...
While Jan. 1 might seem like the most natural day for new laws to take effect, most laws in Georgia passed by the General ...
First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to <22 years) in Q4 2025, with enrollment advancing across ...
The January 5, 2026 decision to revise the US childhood vaccine schedule marks a turning point in the destruction of public ...
Opinion
Former CDC epidemiologist Dr. Fiona Havers speaks on the collapse of evidence-based vaccine policy
The scientist quit the CDC in protest after Trump-appointed Secretary of Health and Human Services Robert F. Kennedy Jr. removed every member of the Advisory Community on Immunization Practices.
Public records clearly shows that for the past 25 years, CERN has repeatedly built inadequate FPGA-based Level-1 Triggers, necessitating multiple rebuilds. During the Higgs boson discovery ...
Detailed price information for Werewolf Therapeutics Inc (HOWL-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results